riluzole has been researched along with B16 Melanoma in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biechele, TL | 1 |
Camp, ND | 1 |
Fass, DM | 1 |
Kulikauskas, RM | 1 |
Robin, NC | 1 |
White, BD | 1 |
Taraska, CM | 1 |
Moore, EC | 1 |
Muster, J | 1 |
Karmacharya, R | 1 |
Haggarty, SJ | 1 |
Chien, AJ | 1 |
Moon, RT | 1 |
1 other study available for riluzole and B16 Melanoma
Article | Year |
---|---|
Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Proliferation; Gene Expression Regulation; Genes, | 2010 |